Post-entry restriction of retroviral infections

AIDS Reviews

Volumn 5, Issue 3, 2003, Pages 156-164

  Towers, Greg J ^a   Goff, Stephen P ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Columbia University ^*  (United States)

Author keywords

Fv1; Lentivirus; Lv1; Ref1; Restriction; Retrovirus

Indexed keywords

CELL PROTEIN; CORE PROTEIN; CYCLOPHILIN; DNA; EPITOPE; FV1 GENE PRODUCT; GAG PROTEIN; GENE PRODUCT; LV1 GENE PRODUCT; REF1 GENE PRODUCT; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

DNA RESTRICTION; EQUINE INFECTIOUS ANEMIA VIRUS; FV1 GENE; GENE; GENETIC CODE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LV1 GENE; MOLECULAR EVOLUTION; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIMATE; REF1 GENE; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION; REVIEW; SUPERINFECTION; VIRUS CAPSID; VIRUS GENOME; VIRUS INHIBITION; VIRUS PATHOGENESIS;

ANIMALS; HUMANS; LENTIVIRUS; MAMMALS; MOLONEY MURINE LEUKEMIA VIRUS; RETROVIRIDAE; RETROVIRIDAE INFECTIONS;

EID: 0242288838     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Coffin J, Hughes S, Varmus H. Retroviruses. CSHL Press. 1997.
2. Lander E, Linton L, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
3. Sheehy A, Gaddis N, Choi J, et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002;418:646-50.
4. Ikeda H, Sugimura H. Fv-4 resistance gene: A truncated endogenous murine leukemia virus with ecotropic interference properties. J Virol 1989;63:5405-12.
5. Lilly F. Fv2: Identification and location of a second gene governing the spleen focus response to friend leukemia virus in mice. J National Cancer Inst 1970;45:163-9.
6. Steeves R, Lilly F. Interactions of host and viral genomes in mouse leukemia. Ann Rev Genet 1977;11:277-96.
7. Kozak C, Chakraborti A. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance. Virology 1996;225:300-5.
8. Rowe W, Hartley J. Studies of genetic transmission of murine leukemia virus by AKR mice. II. Crosses with Fv1-b strains of mice. J Exp Med 1972;136:1286-301.
9. Rein A, Kashmiri S, Bassin R, et al. Phenotypic mixing between N- and B-tropic murine leukemia viruses: Infectious particles with dual sensitivity to Fv1 restriction. Cell 1976;7:373-9.
10. Moloney J. Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. J Natl Cancer Inst 1960;24:933-51.
11. Shoemaker C, Goff S, Gilboa E, et al. Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: Implications for retrovirus integration. Proc Natl Acad Sci USA 1980;77:3932-6.
12. Hartley J, Rowe W, Huebner R. Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures. J Virol 1970;5:221-5.
13. Decleve A, Niwa O, Gelmann E, et al. Replication kinetics of N- and B-tropic murine leukemia viruses on permissive and nonpermissive cells in vitro. Virology 1975;65:320-32.
14. Pincus T, Rowe W, Lilly F. A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. J Exp Med 1971;133:1234-41.
15. Tennant R, Otten J, Brown A, et al. Characterization of Fv1 host range strains of murine retroviruses by titration and p30 protein characteristics. Virology 1979;99:349-57.
16. Jolicoeur P, Baltimore D. Effect of the Fv1 locus on the titration of murine leukemia viruses. J Virol 1975;16:1593-8.
17. Bassin R, Duran-Troise G, Gerwin B, et al. Abrogation of Fv1-B restriction with murine leukemia viruses inactivated by heat or by gamma irradiation. J Virol 1978;26:306-15.
18. Duran-Troise G, Bassin R, Rein A, et al. Loss of Fv1 restriction in Balb/3T3 cells following infection with a single N-Tropic murine leukemia virus particle. Cell 1977;10:479-88.
19. Boone L, Innes C, Heitman C. Abrogation of Fv1 restriction by genome-deficient virions produced by a retrovirus packaging cell line. J Virol 1990;64:3376-81.
20. Jolicoeur P, Rassart E. Effect of Fv1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus. J Virol 1980;33:183-95.
21. Yang W, Kiggans J, Yang D, et al. Synthesis and circularization of N- and B-tropic retroviral DNA Fv1 permissive and restrictive mouse cells. Proc Natl Acad Sci USA 1980;77:2994-8.
22. Bassin R, Gerwin B, Levin J, et al. Macromolecular requirements for abrogation of Fv1 restriction by murine leukemia viruses. J Virol 1980;35:287-97.
23. Towers G, Bock M, Martin S, et al. A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci USA 2000;97:12295-9.
24. Yap M, Stoye J. Intracellular localisation of Fv1. Virology 2003;307:76-89.
25. Best S, Le Tissier P, Towers G et al. Positional cloning of the mouse restriction gene Fv1. Nature 1996;382:826-9.
26. Benit L, De Parseval N, Casella J, et al. Cloning of a new murine retrovirus, MuERV-L with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene. J Virol 1997;71:5652-7.
27. Bock M, Bishop K, Towers G, et al. Use of a transient assay for studying the genetic determinants of Fv1 restriction. J Virol 2000;74:7422-30.
28. Bishop K, Bock M, Towers G, et al. Identification of the regions of Fv1 necessary for murine luekemia virus restriction. J Virol 2001;75:5182-8.
29. Towers G, Collins M, Takeuchi Y. Abrogation of Ref1 restriction in human cells. J Virol 2000;76:2548-50.
30. Hatziioannou T, Cowan S, Goff S, et al. Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J 2003;22:1-10.
31. Gao F, Bailes E, Robertson D, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-41.
32. Gao F, Yue L, White A, et al. Human infection by genetically diverse SIVSM-related HIV-2 in West Africa. Nature 1992;358:495-9.
33. Shibata R, Kawamura M, Sakai H, et al. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol 1991;65:3514-20.
34. Shibata R, Sakai H, Kawamura M, et al. Early replication block of human immunodeficiency virus type 1 in monkey cells. J Gen Virol 1995;76:2723-30.
35. Hofmann W, Schubert D, LaBonte J, et al. Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol 1999;73:10020-8.
36. Ikeda Y, Collins M, Radcliffe P, et al. Gene transfer efficiency in cells of different species by HIV and EIAV vectors. Gene Therapy 2002;9:932-8.
37. Besnier C, Takeuchi Y, Towers G. Restriction of lentivirus in monkeys. Proc Natl Acad Sci USA 2002;99:11920-5.
38. Cowan S, Hatziioannou T, Cunningham T, et al. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci USA 2002;99:11914-9.
39. Munk C, Brandt S, Lucero G, et al. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci USA 2002;99:13843-8.
40. Duran-Troise G, Bassin R, Wallace B, et al. Balb/3T3 cells chronically infected with N-tropic murine leukemia virus continue to express Fv1-B restriction. Virology 1981;112:795-9.
41. Dorfman T, Gottlinger H. The HIV type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J Virol 1996;70:5751-7.
42. Fassati A, Goff S. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J Virol 1999;73:8919-25.
43. Fassati A, Goff S. Characterization of intracellular reverse transcription complexes of HIV type 1. J Virol 2001;75:3626-35.
44. Jin Z, Jin L, Peterson D, et al. Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J Mol Biol 1999;286:83-93.
45. Boone L, Glover P, Innes C, et al. Fv1-N and -B tropism-specific sequences in murine leukemia virus and related endogenous proviral genomes. J Virol 1988;62:2644-50.
46. Goff S. Operating under a Gag order: A block against incoming virus by the Fv1 gene. Cell 1996;86:691-3.
47. Mammano F, Ohagen A, Hoglund S, et al. Role of the major homology region of HIV type 1 in virion morphogenesis. J Virol 1994;68:4927-36.
48. Bowzard J, Wills J, Craven R. Second-site suppressors of Rous sarcoma virus CA mutations: Evidence for interdomain interactions. J Virol 2001;75:6850-6.
49. Cairns T, Craven R. Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants. J Virol 2001;75:242-50.
50. McDonald D, Vodicka M, Lucero G, et al. Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002;159:441-52.
51. Berthoux L, Towers G, Gurer C, et al. As2O3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J Virol 2003 (in press).
52. Kozak C. Analysis of wild-derived mice for Fv1 and Fv2 murine leukemia virus restriction loci: A novel wild mouse Fv1 allele responsible for lack of host range restriction. J Virol 1985;55:281-5.
53. Qi C-F, Bonhomme F, Buckler-White A, et al. Molecular phylogeny of Fv1. Mammalian Genome 1998;9:1049-55.
54. Williams L, Cloyd M. Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 1991;184:723-8.
55. Spira A, Ho D. Effect of different donor cells on HIV type 1 replication and selection in vitro. J Virol 1995;69:422-9.
56. Eisert V, Kreutz M, Becker K, et al. Analysis of cellular factors influencing the replication of HIV type 1 in human macrophages derived from blood of different healthy donors. Virology 2001;286:31-44.
57. Kanki P, Kurth R, Becker W, et al. Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera. Lancet 1985;i:1330-2.
58. Ohta Y, Masuda T, Tsujimoto H, et al. Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int J Cancer 1988;41:115-22.
59. Allan J, Short M, Taylor M, et al. Species-specific diversity among simian immunodeficiency viruses from African green monkeys. J Virol 1991;65:2816-28.
60. Johnson P, Fomsgaard A, Allan J, et al. Simian immunodeficiency viruses from African green monkeys display unusual genetic diversity. J Virol 1990;64:1086-92.
61. Fomsgaard A, Hirsch V, Allan J, et al. A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. Virology 1991;182:397-402.
62. Hirsch V, McGann C, Dapolito G, et al. Identification of a new subgroup of SIVagm in tantalus monkeys. Virology 1993;197:426-30.
63. Jin M, Hui H, Robertson D, et al. Mosaic genome structure of simian immunodeficiency virus from West African green monkeys. EMBO J 1994;13:2935-47.
64. Kuhmann S, Platt E, Kozak S, et al. Cooperation of multiple CCR5 coreceptors is required for infections by HIV type 1. J Virol 2000;74:7005-15.
65. Villinger F, Folks T, Lauro S, et al. Immunological and virological studies of natural SIV infection of disease-resistant non-human primates. Immunol Lett 1996;51:59-68.
66. Holzammer S, Holznagel E, Kaul A, et al. High virus loads in naturally and experimentally SIVagm-infected African green monkeys. Virology 2001;283:324-31.
67. Rey-Cuille M, Berthier J, Bomsel-Demontoy M, et al. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol 1998;72:3872-86.
68. Gao G, Guo X, Goff S. Inhibition of retroviral RNA production by ZAP a CCCH-type zinc finger protein. Science 2002;297:1703-6.
69. Cuthbert A, Trott D, Ekong R, et al. Construction and characterization of a highly stable human: Rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet Cell Genet 1995;71:68-76.
70. Koi M, Shimizu M, Morita H, et al. Construction of mouse A9 clones containing a single human chromosome tagged with neomycin-resistance gene via microcell fusion. Jpn J Cancer Res 1989;80:413-8.
71. Rasko J, Battini J, Kruglyak L, et al. Precise gene localization by phenotypic assay of radiation hybrid cells. Proc Natl Acad Sci USA 2000;97:7388-92.
72. Stoye J. An intracellular block to primate lentivirus replication. Proc Natl Acad Sci USA 2002;99:11549-51.
73. Barouch D, Kunstman J, Kuroda M, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002;415:335-9.